Optibrium - Optibrium creates elegant software solutions for small molecule design, optimisation and data analysis

Skip to the content

New Publication:

Imputing Bioactivity Data using Deep
Learning. Read the paper >

Next Event:

CDD Seminar Series; Strategies for data management
14/16/18 October, Oxford/Basel/Munich More >

Design of Drug-like Hepsin Inhibitors against Prostate Cancer and Kidney Stones by Vincent Blay
Practical Applications of Deep Learning to Imputation of Drug Discovery Data by Benedict Irwin
Mechanism and Prediction of UGT Metabolism by Mario Öeren

Copyright © 2019 Optibrium, Ltd. All Rights Reserved.
Optibrium™, StarDrop™, Augmented Chemistry™, Asteris™, Ocura™, Glowing Molecule™, WhichP450™, Auto-Modeller™, Nova™, MPO Explorer™ and Card View™ are trademarks of Optibrium Ltd. Matsy™ is a trademark of NextMove Software Ltd., BIOSTER™ is a trademark of iKem Szolgáltató és Kereskedelmi BT, Derek Nexus™ is a trademark of Lhasa Ltd., torch3D™ is a trademark of Cresset BioMolecular Discovery Ltd., and SeeSAR™ is a trademark of BioSolveIT GmbH.
US Patent Numbers 9,224,098 and 9,367,812

New Publication:

Imputing Bioactivity Data using DeepLearning. Read the paper >

Next Event:

CDD Seminar Series; Strategies for data management14/16/18 October, Oxford/Basel/Munich More >

Imputing Bioactivity Data using Deep
Learning. Read the paper >

CDD Seminar Series; Strategies for data management
14/16/18 October, Oxford/Basel/Munich More >